These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8541174)

  • 1. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
    Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC
    Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.
    Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R
    Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
    N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe heart valve disease on appetite suppressants.
    Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appetite suppressants and pulmonary hypertension: a long-term risk.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
    Tellier P
    Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 11. Valve disease and pulmonary arterial hypertension due to appetite suppressants (update).
    Prescrire Int; 2000 Feb; 9(45):211. PubMed ID: 11503800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 13. Dangers of certain appetite suppressants.
    Prime FJ
    Br Med J; 1969 Jul; 3(5663):177. PubMed ID: 5792926
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
    Humbert M; Deng Z; Simonneau G; Barst RJ; Sitbon O; Wolf M; Cuervo N; Moore KJ; Hodge SE; Knowles JA; Morse JH
    Eur Respir J; 2002 Sep; 20(3):518-23. PubMed ID: 12358323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension.
    Blanpain C; Le Poul E; Parma J; Knoop C; Detheux M; Parmentier M; Vassart G; Abramowicz MJ
    Cardiovasc Res; 2003 Dec; 60(3):518-28. PubMed ID: 14659797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation.
    Abramowicz MJ; Van Haecke P; Demedts M; Delcroix M
    Eur Respir J; 2003 Sep; 22(3):560-2. PubMed ID: 14516151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine.
    Davis WM; Waters IW
    Med Hypotheses; 1997 Dec; 49(6):509-12. PubMed ID: 9466375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
    Olschewski H
    Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.